Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Rationale for glycemic control.

C W Young

    The American Journal of Medicine
    |September 20, 1985
    PubMed
    Summary
    This summary is machine-generated.

    Long-term glycemic control may prevent diabetes complications, but short-term euglycemia only reverses early abnormalities. Intensive insulin therapy is suggested for type I diabetes, while sulfonylureas may benefit type II diabetes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Filariasis; Lymph Scrotum and Varicose Groin Glands: Post-Mortem Examination.

    British medical journal·2010
    Same author

    LEISHMANIA DONOVANI IN THE PERIPHERAL BLOOD.

    The Journal of experimental medicine·2009
    Same author

    The role of generalized pain and pain behavior in tender point scores in fibromyalgia.

    The Journal of rheumatology·2000
    Same author

    A combined system for measuring animal motion activities.

    Journal of neuroscience methods·2000
    Same author

    Ultrasonic analysis of tremorine and cold tremor activity in unanesthetized rats.

    The Chinese journal of physiology·1997
    Same author

    Effect of helical CT on the frequency of sedation in pediatric patients.

    AJR. American journal of roentgenology·1997
    Same journal

    GLP-1 Receptor Agonists and Age-related Macular Degeneration Risk in Diabetes or Non-diabetic Obesity: A Retrospective Cohort Study.

    The American journal of medicine·2026
    Same journal

    Marijuana Use and Acute Myocardial Infarction: Mechanistic Insights, Clinical Implications, and Emerging Challenges.

    The American journal of medicine·2026
    Same journal

    Cave Canem - Beware of the Dog.

    The American journal of medicine·2026
    Same journal

    Risk Factors for 30-day Hospital Readmission After Hospital-at-Home Treatment of Acute Pyelonephritis.

    The American journal of medicine·2026
    Same journal

    Mesenteric Panniculitis.

    The American journal of medicine·2026
    Same journal

    Hypercalcemia and hyperferritinemia in a patient with Graves' disease disease.

    The American journal of medicine·2026
    See all related articles

    Area of Science:

    • Endocrinology
    • Diabetology
    • Vascular Medicine

    Background:

    • Chronic vascular complications are a major concern in both type I (insulin-dependent) and type II (non-insulin-dependent) diabetes mellitus.
    • Microangiopathy contributes significantly to morbidity and mortality in type I diabetes, whereas macroangiopathy is more related to outcomes in type II diabetes.

    Purpose of the Study:

    • To investigate the impact of long-term glycemic control on preventing chronic vascular complications in diabetes mellitus.
    • To evaluate the reversibility of diabetic abnormalities with short-term euglycemia.
    • To assess the safety and efficacy of different therapeutic approaches for glycemic control in type I and type II diabetes.

    Main Methods:

    • Review of existing literature on glycemic control and vascular complications in diabetes.

    Related Experiment Videos

  • Analysis of the effects of short-term euglycemia on preclinical and clinical diabetic abnormalities.
  • Comparison of intensive insulin therapy for type I diabetes with sulfonylurea therapy for type II diabetes.

    • Main Results:

    • Short-term euglycemia can reverse preclinical, functional, renal, and retinal abnormalities but not established clinical nephropathy and retinopathy.
    • Intensive insulin therapy for type I diabetes carries a risk of hypoglycemic encephalopathy.
    • Sulfonylurea therapy in type II diabetes may reduce atherosclerosis risk by improving hyperglycemia and lipid profiles with fewer adverse reactions.

    Conclusions:

    • The efficacy of long-term glycemic control in preventing chronic vascular complications of diabetes remains uncertain.
    • Therapeutic strategies should be tailored to diabetes type, considering potential risks and benefits.
    • Early intervention with glycemic control may be crucial for preventing the progression of microvascular and macrovascular complications.